Hereditary deficiency of glucose-6-phosphate dehydrogenase (G-6-PD) in the erythrocyte is generally characterized by a marked increase in hemolysis after administration of various compounds such as primaquine, sulfonamides, and other drugs (1) (2) (3) . In some instances, a chronic hemolytic condition is observed in the absence of drug administration (4, 5) . The former state is classed as drug sensitivity and the latter as congenital nonspherocytic hemolytic anemia (CNSHA) (3) (4) (5) . The observed low level of G-6-PD catalytic activity may be attributed to either a quantitative difference in enzyme concentration or to a qualitative abnormality of the enzyme in the deficient patient (3, 6) .
Characterization of the erythrocyte G-6-PD from normal and drug-sensitive male Negro patients has been reported (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . The enzyme from the drug-sensitive Negro male was indistinguishable from that of normal Negro males with respect to substrate and inhibitor affinity, pH optimum, and general stability (7) .
Nonanemic Caucasian G-6-PD-deficient subjects exhibit qualitative enzyme abnormalities characterized by abnormal Michaelis constants (Km) for glucose-6-phosphate (G-&P) and 2-deoxyglucose-6-phosphate (2-d-G-6-P) (9, 11, 18) . Abnormal electrophoretic mobility and thermal stability have also been observed in some subjects. Similarly, CNSHA subjects have demonstrated abnormalities ranging from only decreased thermostability to high G-6-P Km values and varied electrophoretic mobilities suggesting the existence * Submitted for publication September 25, 1964 ; accepted February 10, 1966. Supported in part by grant AM-07286 from the National Institutes of Health.
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Male Negroes have either an electrophoretically fast moving G-6-PD (A) or a slower moving G-6-PD (B). Since normal Caucasians possess only the slower B G-6-PD, this is generally referred to as the normal enzyme. Drug-sensitive male Negro subjects have either a fast G-6-PD mobility that cannot be distinguished by electrophoresis from A or, rarely, a slow G-6-PD mobility that cannot be distinguished from normal G-6-PD (B). Caucasian deficient and CNSHA subjects may have either a fast mobility comparable to A, a normal slow mobility comparable to B, or a slower mobility than B (18) .
Of particular interest is the variation in the Km reported for the normal enzyme. Although 2.1 x 10-6 mole per L and 3.9 X 10-5 mole per L are the Km values commonly reported for nicotinamide adenine dinucleotide phosphate (NADP) and G-6-P, respectively (12) (13) (14) , some investigators have reported higher values (7, 11, 14, 17) . The reported activation of drug-sensitive erythrocyte G-6-PD by normal stroma (8) has not been fully substantiated (7) .
In the present investigation, erythrocyte G-6-PD from normal and deficient male subjects has been characterized in detail. The results suggest the classification of the deficient Negro into at least three groups with respect to G-6-PD characteristics. One group is indistinguishable from the normal enzyme (quantitative difference), whereas the other two show marked variation (qualitative difference). The G-6-PD from the subjects with CNSHA differs qualitatively from normal G-6-PD. Methods
AssaY procedure. The assay for G-6-PD was performed by following the change in absorbancy at 340 m/u 823 at convenient intervals (5 seconds) in a Beckman DU spectrophotometer adapted for recording and scale expansion (Gilford). Temperature control was obtained by circulating water from a thermostat through thermospacers at both ends of the cell compartment. Unless otherwise stated, NADP reduction was measured at 250 C as a function of time in a system consisting of 300 imoles Tris buffer, pH 8.0, 20 /Amoles MgC12, 1.8 Amoles G-6-P, 0.6 /mole NADP, and enzyme and water to a total volume of 3 ml. The light path was 1.0 cm. One unit of activity is defined as the amount of enzyme generating 1.0 jmole of NADPH (absorbancy 6.2) per minute under conditions of the assay. Specific activity is defined as the units of enzyme activity per milligram of protein. Protein was determined by the spectrophotometric method of Warburg and Christian (20) .
Enzyme purification. The enzyme from the erythrocytes of each individual was purified according to the procedure of Kirkman (13) incorporating the DEAEcellulose adsorption method of Chung and Langdon (12) . The G-6-PD from nondeficient subjects could be purified to a specific activity of 60 to 70, whereas that 2.0- (22) with complete correlation between both assay methods.
Fresh blood samples were centrifuged at 3,000 g for 10 minutes and the supernatant plasma and top layer containing leukocytes discarded, The packed erythrocytes were washed three times with 5 vol of physiological saline. A hematocrit reading was taken of the final saline suspension. The washed cells were then hemolyzed by mixing with 5 vol of a 7 mM solution of f-mercaptoethanol in distilled water. After 30 minutes the stroma was removed by centrifugation at 30,000 g for 20 minutes. The supernatant was assayed immediately for G-6-PD as described and the activity observed related directly to the red blood cell content as determined by the hematocrit.
Results
Erythrocyte G-6-PD levels. The G-6-PD activity in human erythrocytes from male Caucasian and Negro subjects is summarized in Table I . The normal range of G-6-PD activity is 100 to 1 Glucosamine-6-phosphate obtained from Nutritional Biochemicals Corp., Cleveland, Ohio, and other substrates from Sigma Chemical Co., St. Louis, Mo.
2 Bio-Rad Laboratories, Richmond, Calif.
3 Nutritional Biochemicals Corp., 3,4,5 dimethyl thiazolyl 1-2) 2,5 diphenyl tetrazolium bromide. 160 U per 100 ml packed red blood cells for both Negro and Caucasian subjects. The drug-sensitive Negro subjects had activity levels of 24 to 41 U per 100 ml packed red blood cells, whereas the CNSHA subjects had a range of 4 to 20. Activation energy. The effect of temperature on the velocity of the purified enzymes is illustrated in Figure 1 . The average activation energy value, Ea, for the normal subjects and individual values for the deficient subjects are given in Ta mal subjects were 9.7 kcal per mole below 300 C and 5.7 kcal per mole above 400 C. Subject L.B., like the normal subjects, gave an E. of 10.0 kcal per mole below 30°C and 5.3 kcal per mole above 400 C. Subject J.P., however, had an Ea of 5.0 kcal per mole below 300 C, which is significantly lower than that of normal subjects, and 6.3 kcal per mole above 400 C. The remaining deficient Negro subjects, F.H., H.R., E.E., B.C., and N.M., had an Ea of approximately 5.0 kcal per mole below 30°C and 10.0 kcal per mole above 40°C, which is the reverse of the pattern obtained with normal subjects. An Ea of 9.3 kcal per mole below 30°C was found for CNSHA subjects, which is comparable to the normal subjects, but the Ea above 40°C could not be determined due to the extreme thermal lability of the enzyme.
Michaelis constants. The Km values for G-6-P and NADP with G-6-PD were determined for each of the subjects. Two Km values for G-6-P ( Figure 2 ) and four for NADP (Figure 3 Table III . Deficient subject L.B. is identical with the normal, but the remaining six deficient subjects demonstrate only the lower Km values (one for G-6-P and two for NADP). The CNSHA subjects possess single G-6-P and NADP Km values approximating the highest values obtained with the normals.
The degree of purity of the normal enzyme had no effect on the values of the kinetic parameters. Identical results were obtained for the normal enzyme whether enzyme of specific activity 0.5 or 70 was employed as well as with deficient subject 826 TYPES OF HUMAN ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE 9 .0 on the catalytic activity of G-6-PD was studied. At pH 9.0, G-6-PD from normal subjects and deficient subject L.B. gave higher catalytic activity with Tris buffer than with glycine buffer. The G-6-PD from the remaining deficient subjects had higher catalytic activity with glycine rather than with Tris, suggesting a charge difference between the two groups of enzyme. In every enzyme preparation, increasing the concentration of the Tris or glycine buffer from 0.001 mole per L to 0.1 mole per L stimulated the reaction velocity. However, such an increase in the concentration-of the phosphate buffers decreased the velocity of the reaction, indicating inhibition by phosphate ion.
Substrate specificity. The Km values for substrates other than G-6-P and NADP are presented in Table IV . Normal subjects gave a single Km value for galactose-6-phosphate (gal-6-P) and two Km values for 2-d-G-6-P. Deficient subject L.B. showed normal Km values for both substrates. Deficient subject J.P. had the same gal-6-P Km as the normal, but only the higher 2-d-G-6-P Km.
The remaining deficient subjects showed no activity towards gal-6-P at the 250 C temperature employed and only the lower normal Km value for 2-d-G-6-P. At 50°C they demonstrated slight catalytic activity towards gal-6-P, but no Km values could be determined. The CNSHA subjects gave a high Km value for gal-6-P and only the higher normal Km value for 2-d-G-6-P. No activity towards glucosamine-6-phosphate was observed with G-6-PD from any of the subjects.
Electrophoresis. The electrophoretic mobilities of the normal and deficient enzyme are shown in Ea. 400-500 C, kcal/mole Km X 106 G-6-P G-6-P NADP NADP NADP NADP Km X 103
Gal Discussion The parameters of G-6-PD investigated suggest the existence of four biochemically distinguishable enzyme types in the deficient human subjects employed in this study The characteristics of each group are summarized in Table V . Deficient enzyme types I and III comprise only single deficient subjects, L.B. and J.P., respectively. Deficient enzyme type II is composed of five deficient subjects, F.H., H.R., E.E., B.C., and N.M. The CNSHA subjects employed comprise deficient enzyme type IV, which appears to be only one of several qualitatively different G-6-PD enzyme types reported for CNSHA subjects (19) .
The determination of two Km values for G-6-P with normal G-6-PD suggests the presence of two catalytic sites on the enzyme (23, 24) . The implications of two catalytic sites with respect to supporting evidence and reaction mechanisms will be discussed elsewhere (25) . However, the similarity of Km values that could be determined with each of the normal and deficient enzymes suggests that the qualitative differences observed in this investigation may be due to the absence or lack of activity at one or the other of the two catalytic sites.
Qualitative differences in G-6-PD based on kinetic data have been reported only for CNSHA subjects and Caucasian drug-sensitive males (6, 9, 11, 18, 19) . The G-6-PD from our CNSHA subjects is characterized by a fast electrophoretic pattern, a higher than normal Km value for G-6-P, and a marked thermal instability. Thus the enzyme deficiency of our CNSHA subjects is apparently also due to a qualitative enzyme abnormality.
The detailed characterization of deficient enzyme type I demonstrates that it is identical with the normal enzyme in all of the parameters investigated. Consequently, the deficiency observed may be attributed to lower enzyme concentration and not to a lower reaction rate due to enzyme abnormality. Therefore in type I we have a quantitative difference in G-6-PD between the normal and deficient subject.
Deficient enzyme types II, III, and IV may be (6) in their recent review of the variations of G-6-PD in different populations have reported that, with one exception, Negro enzyme-deficient subjects show a fast electrophoretic component. The enzyme characteristics of the G-6-PD-deficient Negro who showed the slow band are not available in Porter's report (6) . We would predict that this individual's G-6-PD would show the characteristics of our type I.
More recently, Kirkman, McCurdy, and Naiman (18) have summarized the published data on patients with functionally abnormal G-6-PD. Although several variants have been found in the Caucasians, all those seen in Negroes have been classified as electrophoretic type A-, with the exception cited by Porter and associates (6) .
Porter and associates (6) have stated that there appears to be extensive genetic heterogeneity of G-6-PD among subjects with the uncommon forms of enzyme deficiency. The electrophoretic mobility of the G-6-PD obtained from the Italian family named Barbieri reported by Marks, Banks, and Gross (11) was faster than normal type B and also faster than type A. Although both parents of one of our Caucasian CNSHA patients and the mother of the other have an Italian background, their G-6-PD electrophoretic mobility is similar to type A. The family of Marks and colleagues, however, is atypical in that the red cell G-6-PD level is about one-half of normal, in contrast to the extremely low levels in our two patients and those reported by others for Caucasians with CNSHA. Kirkman and associates have reported patients with CNSHA with G-6-PD electrophoretic mobility similar to normal Caucasians, type B ( 18, 19) . The patient designated "Eysson" by Boyer and colleagues (16) showed a slower mobility than type B. Obviously, comparative studies of these more unusual deficient patients should be carried out. Summary Glucose-6-phosphate dehydrogenase from erythrocytes of normal and enzyme-deficient subjects 'has been characterized in detail. The comparison of a number of parameters from drug-sensitive, nonanemic, Negro males indicates the existence of three qualitatively different enzyme types. Type I is indistinguishable from the normal Negro enzyme, having a slow type B electrophoretic pattern and identical activation energies and kinetic constants. Types II and III give a fast type A electrophoretic pattern and abnormal activation energies and kinetic constants. However, although types II and III could not be distinguished fronm each other electrophoretically, they could be separately characterized on the basis of their activation energies, substrate specificity, and kinetic constants for 2-deoxyglucose-6-phosphate. Par 
